Amussen Hunsaker Associates LLC raised its stake in Healthequity Inc (NASDAQ:HQY) by 1.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 237,239 shares of the company’s stock after purchasing an additional 4,493 shares during the period. Healthequity accounts for approximately 9.8% of Amussen Hunsaker Associates LLC’s investment portfolio, making the stock its 2nd biggest position. Amussen Hunsaker Associates LLC owned approximately 0.39% of Healthequity worth $12,000,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the business. Zions Bancorporation bought a new stake in shares of Healthequity in the third quarter valued at about $119,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Healthequity by 105.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock valued at $127,000 after acquiring an additional 1,308 shares during the period. Riverhead Capital Management LLC boosted its position in shares of Healthequity by 75.3% in the second quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock valued at $131,000 after acquiring an additional 1,129 shares during the period. Oppenheimer Asset Management Inc. boosted its position in shares of Healthequity by 7.7% in the second quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock valued at $134,000 after acquiring an additional 191 shares during the period. Finally, Fortaleza Asset Management Inc. bought a new stake in shares of Healthequity in the second quarter valued at about $138,000. Hedge funds and other institutional investors own 98.60% of the company’s stock.
Shares of Healthequity Inc (HQY) opened at $43.69 on Tuesday. Healthequity Inc has a 52-week low of $37.62 and a 52-week high of $55.31. The firm has a market cap of $2,773.95, a PE ratio of 65.31, a P/E/G ratio of 1.98 and a beta of 1.74.
A number of equities research analysts have recently issued reports on HQY shares. BidaskClub cut shares of Healthequity from a “hold” rating to a “sell” rating in a research report on Thursday, December 7th. Zacks Investment Research cut shares of Healthequity from a “buy” rating to a “hold” rating in a research report on Wednesday, November 15th. Cantor Fitzgerald reissued a “buy” rating and issued a $56.00 target price on shares of Healthequity in a research report on Tuesday, September 5th. Chardan Capital boosted their target price on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research report on Wednesday, December 6th. Finally, Robert W. Baird reissued a “hold” rating on shares of Healthequity in a research report on Thursday, September 21st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eight have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $58.33.
In other Healthequity news, insider Stephen Neeleman sold 8,500 shares of the business’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $45.24, for a total transaction of $384,540.00. Following the completion of the transaction, the insider now owns 1,000 shares of the company’s stock, valued at $45,240. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Frank Medici sold 419,504 shares of the business’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $52.97, for a total value of $22,221,126.88. Following the transaction, the director now directly owns 6,381 shares of the company’s stock, valued at approximately $338,001.57. The disclosure for this sale can be found here. Insiders have sold 1,743,212 shares of company stock valued at $91,145,351 in the last ninety days. 19.00% of the stock is currently owned by company insiders.
WARNING: This report was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://stocknewstimes.com/2017/12/12/healthequity-inc-hqy-is-amussen-hunsaker-associates-llcs-2nd-largest-position.html.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).
Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with MarketBeat.com's FREE daily email newsletter.